These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A 3D human neural cell culture system for modeling Alzheimer's disease. Kim YH; Choi SH; D'Avanzo C; Hebisch M; Sliwinski C; Bylykbashi E; Washicosky KJ; Klee JB; Brüstle O; Tanzi RE; Kim DY Nat Protoc; 2015 Jul; 10(7):985-1006. PubMed ID: 26068894 [TBL] [Abstract][Full Text] [Related]
4. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models. Götz J; Schild A; Hoerndli F; Pennanen L Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275 [TBL] [Abstract][Full Text] [Related]
5. Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders. Mold MJ; O'Farrell A; Morris B; Exley C J Alzheimers Dis; 2020; 78(1):139-149. PubMed ID: 32925074 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology. Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050 [TBL] [Abstract][Full Text] [Related]
7. Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease. Kwak SS; Washicosky KJ; Brand E; von Maydell D; Aronson J; Kim S; Capen DE; Cetinbas M; Sadreyev R; Ning S; Bylykbashi E; Xia W; Wagner SL; Choi SH; Tanzi RE; Kim DY Nat Commun; 2020 Mar; 11(1):1377. PubMed ID: 32170138 [TBL] [Abstract][Full Text] [Related]
8. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease. Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903 [TBL] [Abstract][Full Text] [Related]
9. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease. Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552 [TBL] [Abstract][Full Text] [Related]
10. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
11. Mouse models of Alzheimer's disease: the long and filamentous road. Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012 [TBL] [Abstract][Full Text] [Related]
12. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985 [TBL] [Abstract][Full Text] [Related]
13. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Maccioni RB; Muñoz JP; Barbeito L Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751 [TBL] [Abstract][Full Text] [Related]
14. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease. Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371 [TBL] [Abstract][Full Text] [Related]
15. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488 [TBL] [Abstract][Full Text] [Related]
17. Amyloid-β and Tau at the Crossroads of Alzheimer's Disease. Gallardo G; Holtzman DM Adv Exp Med Biol; 2019; 1184():187-203. PubMed ID: 32096039 [TBL] [Abstract][Full Text] [Related]
18. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease. Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574 [TBL] [Abstract][Full Text] [Related]